Latest News
March 22, 2022
Nucleai closes $33 Million Series B financing to advance its spatial biology platform for drug research, Development and diagnostics
February 14, 2022
Oncomfort announced the appointment of Karl Schweitzer as Chairman of the Board
January 10, 2022
Debiopharm invests in VeriSIM Life’s $15m series A round to advance AI-enabled drug research
January 6, 2022
VeriSIM Life closes $15M series A round to advance AI-enabled drug research
December 17, 2021
BC platforms announced a new clinical collaboration with the Colorado Center for Personalized Medicine (CCPM)
December 14, 2021
Mekonos announces a new partnership with Neochromosone to advance cell engineering for personalized medicine